International Assets Investment Management LLC Buys 2,272 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

International Assets Investment Management LLC increased its stake in U.S. Physical Therapy, Inc. (NYSE:USPHFree Report) by 8,414.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,299 shares of the company’s stock after purchasing an additional 2,272 shares during the period. International Assets Investment Management LLC’s holdings in U.S. Physical Therapy were worth $195,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of USPH. Norden Group LLC raised its position in U.S. Physical Therapy by 37.5% in the 1st quarter. Norden Group LLC now owns 4,528 shares of the company’s stock worth $511,000 after purchasing an additional 1,235 shares during the last quarter. BNP Paribas Financial Markets raised its position in U.S. Physical Therapy by 6.8% in the 1st quarter. BNP Paribas Financial Markets now owns 7,837 shares of the company’s stock worth $885,000 after purchasing an additional 502 shares during the last quarter. GSA Capital Partners LLP raised its position in U.S. Physical Therapy by 110.3% in the 1st quarter. GSA Capital Partners LLP now owns 7,909 shares of the company’s stock worth $893,000 after purchasing an additional 4,149 shares during the last quarter. Texas Permanent School Fund Corp raised its position in U.S. Physical Therapy by 1.3% in the 1st quarter. Texas Permanent School Fund Corp now owns 13,116 shares of the company’s stock worth $1,480,000 after purchasing an additional 170 shares during the last quarter. Finally, Envestnet Portfolio Solutions Inc. bought a new position in U.S. Physical Therapy in the 1st quarter worth approximately $391,000.

Analysts Set New Price Targets

USPH has been the subject of a number of analyst reports. StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday, August 21st. Barrington Research reaffirmed an “outperform” rating and set a $108.00 target price on shares of U.S. Physical Therapy in a report on Wednesday, October 9th. Finally, Bank of America reaffirmed a “neutral” rating and set a $90.00 target price (down previously from $114.00) on shares of U.S. Physical Therapy in a report on Monday, October 7th.

Read Our Latest Stock Report on U.S. Physical Therapy

Insider Activity

In other news, COO Graham D. Reeve sold 1,724 shares of the business’s stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total value of $142,230.00. Following the completion of the transaction, the chief operating officer now owns 7,038 shares of the company’s stock, valued at $580,635. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, Director Kathleen A. Gilmartin acquired 2,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were acquired at an average cost of $86.09 per share, with a total value of $172,180.00. Following the transaction, the director now owns 18,904 shares of the company’s stock, valued at $1,627,445.36. The trade was a 0.00 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Graham D. Reeve sold 1,724 shares of the business’s stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total transaction of $142,230.00. Following the completion of the sale, the chief operating officer now directly owns 7,038 shares in the company, valued at $580,635. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.70% of the stock is owned by company insiders.

U.S. Physical Therapy Price Performance

USPH opened at $97.10 on Thursday. The company has a fifty day moving average price of $83.21 and a two-hundred day moving average price of $91.53. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.88 and a current ratio of 1.88. U.S. Physical Therapy, Inc. has a 52 week low of $76.18 and a 52 week high of $113.63. The firm has a market capitalization of $1.46 billion, a PE ratio of 91.60, a P/E/G ratio of 3.93 and a beta of 1.38.

U.S. Physical Therapy (NYSE:USPHGet Free Report) last announced its quarterly earnings results on Tuesday, November 5th. The company reported $0.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.68 by $0.01. U.S. Physical Therapy had a net margin of 4.06% and a return on equity of 8.18%. The company had revenue of $168.03 million during the quarter, compared to analyst estimates of $163.97 million. As a group, analysts anticipate that U.S. Physical Therapy, Inc. will post 2.58 earnings per share for the current year.

U.S. Physical Therapy Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 15th will be issued a $0.44 dividend. This represents a $1.76 annualized dividend and a dividend yield of 1.81%. The ex-dividend date is Friday, November 15th. U.S. Physical Therapy’s dividend payout ratio (DPR) is 166.04%.

U.S. Physical Therapy Company Profile

(Free Report)

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Stories

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.